---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-027387"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T21:30:45.617364+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Sonim board members Alan Howe and Jose Principe to retire; Howe to remain as consultant

## Summary
- Alan Howe and Jose Principe will not stand for re-election at Sonim's 2023 annual meeting.
- Howe signed a one-year consulting agreement with a $25,000 annual retainer, effective after the meeting.
- Howe's unvested equity awards will continue vesting as if he remained on the board.
- Both retirements are not due to any disagreement with company operations or policies.
- Consulting agreement includes confidentiality, non-disclosure, and non-disparagement covenants.

## SEC filing metadata
- accession: 0001493152-23-027387
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315223027387/0001493152-23-027387-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315223027387/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-027387
- JSON: https://secwatch.observer/filing/0001493152-23-027387.json
- Plain text: https://secwatch.observer/filing/0001493152-23-027387.txt

## Key facts
- Executive change
  Alan Howe retired as Director at DNA X, Inc..
  - Action: retired
  - Role: Director
  source text: On August 3, 2023, Alan Howe informed the board of directors (the “Board”) of Sonim Technologies, Inc. (the “Company”) of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315223027387/0001493152-23-027387-index.htm
- Executive change
  Jose C. Principe retired as Director at DNA X, Inc..
  - Action: retired
  - Role: Director
  source text: On August 3, 2023, Jose C. Principe informed the Board of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000149315223027387/0001493152-23-027387-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.